Tada Hiroomi 4
4 · Tyra Biosciences, Inc. · Filed Aug 1, 2023
Insider Transaction Report
Form 4
Tada Hiroomi
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-07-28+115,000→ 115,000 totalExercise: $14.35Exp: 2033-07-27→ Common Stock (115,000 underlying)
Footnotes (1)
- [F1]1/48th of the shares subject to the option vest monthly following July 28, 2023, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.